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Abstract
The respiration, membrane potential (∆ψ), and oxidative phosphory-
lation of mitochondria in situ were determined in spheroplasts ob-
tained from Candida albicans control strain ATCC 90028 by lyticase
treatment. Mitochondria in situ were able to phosphorylate externally
added ADP (200 µM) in the presence of 0.05% BSA. Mitochondria in
situ generated and sustained stable mitochondrial ∆ψ respiring on 5
mM NAD-linked substrates, 5 mM succinate, or 100 µM N,N,N’,N’-
tetramethyl-p-phenylenediamine dihydrochloride plus 1 mM ascor-
bate. Rotenone (4 µM) inhibited respiration by 30% and 2 µM
antimycin A or myxothiazole and 1 mM cyanide inhibited it by 85%.
Cyanide-insensitive respiration was partially blocked by 2 mM benzo-
hydroxamic acid, suggesting the presence of an alternative oxidase.
Candida albicans mitochondria in situ presented a carboxyatractylo-
side-insensitive increase of ∆ψ induced by 5 mM ATP and 0.5% BSA,
and ∆ψ decrease induced by 10 µM linoleic acid, both suggesting the
existence of an uncoupling protein. The presence of this protein was
subsequently confirmed by immunodetection and respiration experi-
ments with isolated mitochondria. In conclusion, Candida albicans
ATCC 90028 possesses an alternative electron transfer chain and
alternative oxidase, both absent in animal cells. These pathways can
be exceptional targets for the design of new chemotherapeutic agents.
Blockage of these respiratory pathways together with inhibition of the
uncoupling protein (another potential target for drug design) could
lead to increased production of reactive oxygen species, dysfunction
of Candida mitochondria, and possibly to oxidative cell death.
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Introduction
Candidiases are common infections of
the skin, oral cavity, esophagus, gastrointes-
tinal tract, vagina, and vascular system, and
have become a major cause of mortality in
immunocompromised patients, including
those with AIDS (1-3) or debilitated in some
other way (4). From 2001 to 2003, a total of
2803 Candida spp strains were isolated from
various tissues of patients from the Univer-
sity of Campinas Hospital, UNICAMP, Bra-
zil (5). The strains were identified and classi-
fied into the following species: C. albicans
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(57%), C. tropicalis (13%), C. glabrata
(10%), C. parapsilosis (6%), and C. krusei
(3.4%), and 10.6% belonged to other yeast
genera (5). The chemotherapy currently used
against these fungi has a number of deficien-
cies such as low specificity, toxicity, and
drug resistance. Most antifungal drugs react
with ergosterol or inhibit its production (6);
however, there is an alarming increase in
resistance to antifungal agents (3,7). There-
fore, it is very important to search for bio-
logical targets that could be exploited for the
rational development of improved therapies.
Mitochondria are the major source of
cellular aerobic energy generated by oxida-
tive phosphorylation. C. parapsilosis mito-
chondria possess three types of respiratory
pathways (8): i) the classical respiratory
chain, ii) a secondary parallel respiratory
chain (PAR) consisting of alternative ubi-
quinone, cytochromes (cytbPAR and cytcPAR),
and a terminal oxidase (oxcPAR) insensitive
to antimycin A but inhibited by amytal (9)
and by high concentrations of salicylhydrox-
amic acid (SHAM), myxothiazol (10), and
KCN (11), and finally iii) the constitutive
alternative oxidase (12,13). The high resis-
tance of C. parapsilosis to drugs (14) has
been attributed to the presence of these two
alternative electron transfer systems (8).
Recently, Helmerhorst et al. (13) reported
that C. albicans also contains a variety of
respiratory systems whose expression de-
pends on growth conditions. The authors
reported that the C. albicans ability to regu-
late the expression of individual complexes
and the partitioning of electrons between
both respiratory chains may be the reason
why the cells can survive under conditions
of oxidative stress.
Another mechanism of cell protection
against oxidative stress may involve the re-
cently described isoforms of uncoupling pro-
tein (UCP, now UCP1; 15). The demonstra-
tion of various UCP homologues in plants
(16-18) and animals (17-18) raised the ques-
tion of their true physiological role (18-21)
that should be more general than that of
UCP1 - the production of heat in brown
adipose tissue of hibernating mammals (15).
Evidence has been presented that the new
UCPs are involved in cell defense against
oxidative stress (22-27). They are able to
induce mild uncoupling, thus increasing the
rate of respiration and decreasing the pro-
duction of reactive oxygen species (ROS)
(24-27).
A UCP was also detected recently in C.
parapsilosis (28). Therefore, it is of great
interest to study C. albicans UCP in order to
understand its role in the ability of these cells
to resist stress. In the present study, we dem-
onstrated that spheroplasts obtained from
cultures of C. albicans in the middle of their
exponential phase of growth possess intact
mitochondria able to phosphorylate ADP
and an uncoupling protein (CaUCP) homolo-
gous to the previously described C. parapsi-
losis UCP (CpUCP) (28).
Material and Methods
Candida albicans
C. albicans ATCC 90028 was obtained
from the American Type Culture Collection.
It is a quality control strain for antifungal
susceptibility testing and was maintained in
sterile water and Sabouraud Dextrose Agar
(BD, Difco, Franklin Lakes, NJ, USA). The
cell cultures were grown in YEPG medium
(29) at 37ºC and 200 rpm. To determine the
inflexion point of exponential growth,
samples were collected at 1-h intervals and
culture density was determined spectropho-
tometrically at 530 nm. Experimental points
were fitted using a logistic dose-response
model and the maximum growth rate during
the exponential phase was calculated as its
power parameter.
Spheroplast preparation
One liter of culture was harvested by
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centrifugation for the standard preparation
(29) and cells were washed once with cold
water and once with buffer A (1 M sorbitol,
10 mM MgCl2, and 50 mM Tris-HCl, pH
7.8). Cells were resuspended in buffer A (3
ml/g of cells) supplemented with 30 mM
dithiothreitol. After 15 min at room temper-
ature with shaking, cells were harvested,
resuspended in buffer A containing lyticase
(1 mg/g of cells) and 1 mM DTT, and incu-
bated at 30ºC until about 90% of cells were
converted to spheroplasts (~60 min). The
reaction was stopped with an equal volume
of ice-cold buffer A and spheroplasts were
washed twice with buffer A. The protein
concentration of the final suspension was
determined by the biuret method (30) in the
presence of 0.2% deoxycholate.
Isolation of mitochondria
The spheroplasts were resuspended in
buffer B1 (0.6 M mannitol, 1 mM EDTA,
0.5% BSA, 1 mM PMSF, and 10 mM Tris-
HCl, pH 7.4). Spheroplasts were broken
mechanically using a Dounce homogenizer
with a maximum of 10 strokes and cell de-
bris were removed by centrifugation at 1,000
g for 10 min. Mitochondria were pelleted by
10-min centrifugation at 10,500 g and washed
with buffer B2 (0.6 M mannitol, 1 mM EDTA,
1% BSA, 10 mM Tris-HCl, pH 7.0). The last
wash was made in buffer B2 medium without
BSA and EDTA (28) and mitochondrial pro-
tein concentration was determined by the
biuret method (30).
Mitochondrial membrane potential
The mitochondrial membrane potential
(∆ψ) of permeabilized cells was monitored
by measuring the fluorescence spectrum of
safranine O with a Hitachi F4500 fluores-
cence spectrophotometer (Hitachi, Tokyo,
Japan) at excitation-emission wavelength of
495-586 nm (31). All experiments were per-
formed at 28ºC in 2 ml of standard incuba-
tion medium containing 125 mM sucrose, 65
mM KCl, 10 mM HEPES, pH 7.2, 2.5 mM
KH2PO4, and 1 mM MgCl2, plus 1 mg mito-
chondrial protein.
Oxygen uptake
Oxygen uptake was measured polaro-
graphically at 28ºC using a Clark-type elec-
trode (Yellow Springs Instruments, Yellow
Springs, OH, USA) in 1.3 ml of standard
incubation medium containing 1 mg mito-
chondrial protein (28).
Immunodetection of Candida albicans UCP
Fifty micrograms of total proteins extract-
ed from spheroplasts prepared from cultures
of C. albicans and C. parapsilosis (positive
control) was separated on 10% polyacryl-
amide gel by standard SDS-PAGE. Protein
bands were transferred to a nylon membrane
(Hybond N) with a semi-dry blotting appara-
tus (Amersham Biosciences AB (Pharma-
cia) Uppsala, Sweden). The membrane was
blocked overnight in 20 mM Tris-HCl, pH
7.4, 137 mM NaCl, 0.1% (v/v) Tween 20,
and 10% (w/v) non-fat dry milk and incu-
bated with the anti-AtPUMP1 polyclonal
antibody (1:1000 dilution). After incubation
with an anti-rabbit IgG alkaline phosphatase
conjugate (1:5000 dilution), the membrane
was developed in the dark in 100 mM Tris-
HCl, pH 9.5, 100 mM NaCl, and 12.5 µM
CSPD for 5 min. The bands were visualized
by autoradiography and scanned with the
Eagle-Eye photo documentation system
(Eagle Eye Photo, Homer, AK, USA) (32).
Chemicals
ATP, carbonyl cyanide p-trifluorome-
thoxyphenylhydrazone, succinate, ethylene
ethylenediaminetetraacetic acid, antimycin
A, myxothiazol, carboxyatractyloside (CAT),
BSA, linoleic acid, KCN, N,N,N’,N’-tetra-
methyl-p-phenylenediamine dihydrochloride
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viously applied to C. parapsilosis (29).
In order to search for the presence of
UCP and to examine its activity in these
mitochondria we characterized the classical
respiratory chain and its ability to sustain ∆ψ
by oxidizing different respiratory substrates.
Figure 1 shows that spheroplasts prepared
from cell cultures grown to the middle expo-
nential phase were permeable to mitochon-
drial substrates and inhibitors without af-
fecting the functional integrity of the sphero-
plast mitochondria. These spheroplast mito-
chondria suspended in situ in reaction medi-
um containing a cocktail of NAD-linked sub-
strates generated and sustained a stable mem-
brane potential and respiration rate of 43
nmol O2 min-1 mg protein-1 (Figure 1). The
subsequent inhibition of complex I by 4 µM
rotenone resulted in a decrease of about 30%
in the respiration rate (29 nmol O2 min-1 mg
protein-1) and ∆ψ. This suggests a significant
contribution of this complex to ∆ψ genera-
tion, in agreement with the results obtained
by Helmerhorst et al. (13). They found the
presence of a rotenone-sensitive and a pro-
ton pumping NADH-Q oxidoreductase simi-
lar to complex I in C. albicans ATCC 10231.
The addition of 5 mM succinate restored ∆ψ
but total oxygen consumption level was un-
changed (29 nmol O2 min-1 mg protein-1).
The increase in ∆ψ by succinate addition
was certainly the consequence of an increased
electron flux through the classic respiratory
pathway (coupled respiration - the only one
that increases ∆µH+) associated with some
alteration in the partitioning of electrons
among the three respiratory pathways (clas-
sic, parallel, and via alternative oxidase) pres-
ent in Candida yeast (13), resulting in a
decrease in electron flux through the un-
coupled pathways. Therefore, the total res-
piration rate was not modified by the addi-
tion of succinate. Blockage of complex III by
2 µM antimycin A or 2 µM myxothiazol
promoted collapse of ∆ψ and a reduction of
more than 90% in respiration (4 nmol O2
min-1 mg protein-1). Addition of 100 µM
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Figure 1. Effect of substrates
and inhibitors on Candida albi-
cans spheroplast oxygen con-
sumption (A) and mitochondrial
membrane potential (B). C. albi-
cans spheroplasts (1 mg/ml)
were incubated in reaction me-
dium containing 125 mM su-
crose, 10 mM HEPES, pH 7.2, 2
mM Pi, 1 mM MgCl2, 65 mM
KCl, and 5 mM cocktail (malate,
glutamate, pyruvate, and α-ke-
toglutarate). The additions of the
substrates 5 mM succinate and
100 µM TMPD/ascorbate (TMPD),
and the inhibitors 4 µM rotenone,
2 µM antimycin A (AA) and/or 2
µM myxothiazol (Mix), 1 mM
KCN, and 2 mM BHAM, are indicated by the arrows. Numbers on the trace indicate O2
consumption rates in nmol O2 min-1 mg protein-1. TMPD = tetramethyl-p-phenylenedia-
mine dihydrochloride; BHAM = benzohydroxamic acid.
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Figure 2. Immunodetection of
uncoupling proteins in a total
protein extract of Candida albi-
cans (2 bands in lane Ca) with
polyclonal antibody raised
against Arabidopsis PUMP1. A
C. parapsilosis cell protein ex-
tract containing CpUCP (single
band in lane Cp) was used as a
positive control. The positions
of molecular mass standards are
indicated by the arrows.
(TMPD), and lyticase were purchased from
Sigma (St. Louis, MO, USA). Disodium 3-
(4-methoxyspiro{1,2-dioethane-3,2'-(5'-
chloro) tricyclo [3.3.1.13,7) decane}-4-yl]
phenylphosphate (CSPD) was from Tropix
(Applied Biosystems (Tropix), Foster City,
CA, USA). All other reagents were of ana-
lytical grade.
Results and Discussion
In the present study we characterized
mitochondrial bioenergetic pathways in C.
albicans ATCC 90028 using a method pre-
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TMPD/1 mM ascorbate restored the respira-
tion rate (28 nmol O2 min-1 mg protein-1).
Finally, inhibition of complex IV by 1 mM
KCN was accompanied by a complete loss
of ∆ψ and by a decrease of about 85% in
respiration rate (6 nmol O2 min-1 mg protein-1).
Drastic changes in ∆ψ after inhibition of
complexes III and IV suggest the essential
role of these complexes in energy conserva-
tion by C. albicans mitochondria. The CN--
insensitive respiration was inhibited by 2
mM benzohydroxamic acid, suggesting the
presence of alternative oxidases, as previ-
ously described (8,13). In contrast, Helmer-
horst et al. (13) reported that respiration by
C. albicans ATCC 10231 cells was almost
insensitive to 5 mM SHAM when grown in
the absence of antimycin A. On the other
hand, respiration by cells grown in the pres-
ence of 10 µM antimycin A was completely
inhibited by 5 mM SHAM, indicating that
the alternative pathway was the only path-
way utilized by C. albicans mitochondria
when the classical cytochrome pathway was
inhibited at the cytochrome c oxidase level.
An uncoupling protein, another energy-
dissipating system that can also modulate ∆ψ
and the respiration rate, was recently identi-
fied in the fungus kingdom as CpUCP from C.
parapsilosis (28). Interestingly, UCP is absent
in Saccharomyces cerevisiae (33). In the pres-
ent study, the existence of a CpUCP homo-
logue (CaUCP) was also detected in C. albi-
cans mitochondria by immunoblot analysis
using anti-AtPUMP1 antibody (32) and
CpUCP (line Cp) as a positive control. The
immunoblot revealed 2 protein bands of about
32 kDa (Figure 2, lane Ca) in a sample of total
protein extract from C. albicans cells. The
existence of two bands in C. albicans suggests
the presence of more than one UCP, as ob-
served in mammals and plants (17,18,34,35).
Uncoupling proteins are known to be
activated by free fatty acids (FFAs) and in-
hibited by ATP (36-39). Accordingly, in situ
∆ψ measurements in C. albicans mitochon-
dria demonstrated an increase of ∆ψ after
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Figure 3. Effect of ATP and BSA
(A) or LA (B) on mitochondrial
∆ψ of Candida albicans sphero-
plasts in the presence of 1 µM
CAT. Spheroplasts (1 mg/ml)
were added to standard medi-
um containing 5 mM substrate
cocktail (malate, glutamate,
pyruvate, and α-ketoglutarate)
and 5 µM safranine O. Additions
of 5 mM ATP (line b), 0.5% BSA
(lines b and e), 10 µM LA (line
e), and 1 µM FCCP are indicated
by the arrows. Lines a and d are
controls without additions and
line c is a control with ATP and
BSA present from the beginning
of the experiment. BSA = bo-
vine serum albumin; CAT = car-
boxyatractyloside; ∆ψ = mem-
brane potential; FCCP = carbo-
nyl cyanide p-trifluoromethox-
yphenylhydrazone; LA = linoleic
acid.
consecutive additions of 5 mM ATP and
0.5% BSA, which binds non-covalently FFAs
(Figure 3A, trace b) as compared to control
experiments without additions (trace a). The
dotted line (c) shows the ∆ψ generated by C.
albicans mitochondria in the presence of
ATP and BSA from the beginning of the
experiment. In contrast, the addition of lino-
leic acid caused a decrease in ∆ψ that was
reversed by BSA (Figure 3B, trace e), reach-
ing levels higher than control at the end
(trace d), probably because BSA also binds
the endogenous FFAs. These experiments
were performed in the presence of 1 µM
CAT to prevent the contribution of the ADP/
ATP carrier to the FFA-induced H+ re-up-
take through FFA anion translocation (23).
Indeed, it is known that the ADP/ATP car-
rier in the absence of its substrates ADP and
ATP can translocate FFA (23). In addition,
the presence of glutamate, pyruvate, and
malate/α-ketoglutarate prevented fatty acid
anion transport through the corresponding
carriers (23).
Accordingly, in experiments with iso-
lated C. albicans mitochondria, the ADP/O
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Figure 4. Effect of linoleic acid
(LA) on oxidative phosphoryla-
tion. Candida albicans mitochon-
dria (1 mg/ml) were added (as
indicated by the arrow at
“Mito”) to 1.3 ml standard incu-
bation medium (28ºC) with 5
mM substrate cocktail (malate,
glutamate, pyruvate, and α-ke-
toglutarate) and 200 µM ADP in
the absence or in the presence
of 2 µM LA (+LA). The numbers
on the traces indicate O2 con-
sumption rates in nmol O2 min-1
mg protein-1. RC = respiratory
control; ADP/O = ADP/O ratio.
observed uncoupling of oxidase phosphory-
lation caused by linoleic acid can be attrib-
uted to CaUCP. Figure 5 shows that, in the
presence of ATP and BSA, C. albicans mito-
chondria can efficiently phosphorylate ADP
in situ, as indicated by the transient ∆ψ
decrease induced by the addition of ADP.
The presence of uncoupling protein in
Candida ssp implies a role of this protein in
yeast mitochondrial energy metabolism and
raises the possibility of its involvement in
cell protection against ROS overproduction.
This protective role against ROS has been
described for UCP2 (22) and UCP3 (25).
Mitochondria from underexpressing mice had
significantly higher levels of oxidative dam-
age than wild-type controls (26). In plants,
leaf discs of transgenic tobacco plants over-
expressing AtPUMP1 showed an increase in
the tolerance to oxidative stress promoted by
exogenous hydrogen peroxide compared to
wild-type control plants (24).
The presence in C. albicans of an alterna-
tive electron transfer chain (13) and alterna-
tive oxidase (39) absent in animal cells of-
fers exceptional targets for the design of new
chemotherapeutic agents. Blockage of these
respiratory pathways and/or inhibition of the
uncoupling protein (another target for drug
design) could lead to mitochondrial dys-
function, increased production of ROS, and
possibly to cell death.
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Figure 5. ADP phosphorylation
by Candida albicans spheroplast
mitochondria. Spheroplasts (1.0
mg/ml) were incubated in reac-
tion medium containing 5 mM
substrate cocktail (malate, glu-
tamate, pyruvate, and α-ketoglu-
tarate), 0.05% BSA, and 5 µM
safranine O. Spheroplasts (cells),
200 µM ADP, and 1 µM FCCP
were added where indicated by
the arrows. Dotted line repre-
sents a control experiment with-
out ADP addition. FCCP = carbo-
nyl cyanide p-trifluoromethoxy-
phenylhydrazone.
ratio decreased from 2.4 to 1.1 in the pres-
ence of 2 µM linoleic acid, whereas state 4
respiration, observed after ADP phosphory-
lation, was stimulated by about 75% (Figure
4). These results mean that the linoleic acid-
induced H+ recycling can efficiently divert
energy from oxidative phosphorylation in
state 3 respiration even if the state 3 respira-
tion rate is not modified, in agreement with
Jarmuszkiewicz et al. (28). Therefore, the
References
1. Georgopapadakou NH & Tkacz JS (1995). The fungal cell wall as a
drug target. Trends in Microbiology, 3: 98-104.
2. Rex JH, Pfaller MA, Rinaldi G, Polak A & Galgiani JN (1993). Antifun-
gal susceptibility testing. Clinical Microbiology, 6: 367-381.
3. Sanglard D & Odds FC (2002). Resistance of Candida species to
antifungal agents: molecular mechanisms and clinical conse-
quences. Lancet Infectious Diseases, 2: 73-85.
4. Calderone RA & Fonzi WA (2001). Virulence factors of Candida
albicans. Trends in Microbiology, 9: 327-335.
5. Annual Register of Mycoses “Micoteca” (2003). Departamento de
1461
Braz J Med Biol Res 37(10) 2004
Candida albicans UCP and oxidative phosphorylation
Patologia Clínica, Hospital da Universidade de Campinas, Campi-
nas, SP, Brazil.
6. Diamond RD (1991). The growing problem of mycoses in patients
infected with the human immunodeficiency virus. Reviews of Infec-
tious Diseases, 13: 480-486.
7. Rex JH, Rinaldi G & Pfaller MA (1995). Resistance of Candida
species to fluconazole. Antimicrobial Agents and Chemotherapy,
39: 1-8.
8. Milani G, Jarmuszkiewicz W, Sluse-Goffart CM, Schreiber AZ,
Vercesi AE & Sluse FE (2001). Respiratory chain network in mito-
chondria of Candida parapsilosis: ADP/O appraisal of the multiple
electron pathways. FEBS Letters, 508: 231-235.
9. Camougrand N, Cheyrou A, Henry MF & Guérin M (1988). The
alternative respiratory pathway of the yeast Candida parapsilosis:
oxidation of exogenous NAD(P)H. Journal of General Microbiology,
134: 3195-3204.
10. Camougrand N, Zniber S & Guérin M (1991). The antimycin-A-
insensitive respiratory pathway of Candida parapsilosis: evidence
for a second quinone involved specifically in its functioning. Bio-
chimica et Biophysica Acta, 1057: 124-130.
11. Guérin M & Camougrand N (1986). The alternative oxidase of Can-
dida parapsilosis. European Journal of Biochemistry, 159: 519-524.
12. Wagner AM (1995). A role for active oxygen species as second
messengers in the induction of alternative oxidase gene expression
in Petunia hybrida cells. FEBS Letters, 368: 339-342.
13. Helmerhorst EJ, Murphy MP, Troxler RF & Oppenheim FG (2002).
Characterization of the mitochondrial respiratory pathways in Can-
dida albicans. Biochimica et Biophysica Acta, 1556: 73-80.
14. Camougrand N, Velours G & Guérin M (1986). Resistance of Can-
dida parapsilosis to drugs. Biology of the Cell, 58: 71-78.
15. Ricquier D & Kader JC (1976). Mitochondrial protein alteration in
active brown fat: a sodium dodecyl sulfate-polyacrylamide gel elec-
trophoretic study. Biochemical and Biophysical Research Commu-
nications, 73: 577-583.
16. Vercesi AE, Martins IS, Silva MAF, Leite HMF, Cuccovia IM &
Chaimovich H (1995). PUMPing plants. Nature, 375: 24.
17. Bouillaud F, Couplan E, Pecqueur C & Ricquier D (2001). Homo-
logues of the uncoupling protein from brown adipose tissue (UCP1):
UCP2, UCP3, BMCP1 and UCP4. Biochimica et Biophysica Acta,
1504: 107-119.
18. Borecký J, Maia IG & Arruda P (2001). Mitochondrial uncoupling
proteins in mammals and plants. Bioscience Reports, 21: 201-211.
19. Sluse FE & Jarmuszkiewicz W (2000). Activity and functional inter-
action of alternative oxidase and uncoupling protein in mitochondria
from tomato fruit. Brazilian Journal of Medical and Biological Re-
search, 33: 259-268.
20. Hanák P & Jeñek P (2001). Mitochondrial uncoupling proteins and
phylogenesis - UCP4 as the ancestral uncoupling protein. FEBS
Letters, 495: 137-141.
21. Jeñek P, Costa AD & Vercesi AE (2000). Important amino acid
residues of potato plant uncoupling protein (StUCP). Brazilian Jour-
nal of Medical and Biological Research, 33: 1413-1420.
22. Mattiasson G, Shamloo M, Gido G et al. (2003). Uncoupling protein-
2 prevents neuronal death and diminishes brain dysfunction after
stroke and brain trauma. Nature Medicine, 8: 1062-1068.
23. Skulachev VP (1998). Uncoupling: new approaches to an old prob-
lem of bioenergetics. Biochimica et Biophysica Acta, 1363: 100-
124.
24. Brandalise M, Maia IG, Borecký J, Vercesi AE & Arruda P (2003).
Overexpression of plant uncoupling mitochondrial protein in trans-
genic tobacco increases tolerance to oxidative stress. Journal of
Bioenergetics and Biomembranes, 35: 203-209.
25. Vidal-Puig AJ, Grujic D, Zhang CY et al. (2000). Energy metabolism
in uncoupling protein 3 gene knockout mice. Journal of Biological
Chemistry, 265: 16258-16266.
26. Brand MD, Pamplona R, Portero-Otin M, Requena JR, Roebuck SJ,
Buckingham JA, Clapham JC & Cadenas S (2002). Oxidative dam-
age and phospholipid fatty acyl composition in skeletal muscle
mitochondria from mice underexpressing or overexpressing uncou-
pling protein 3. Biochemical Journal, 368: 597-603.
27. Camougrand N, Velours G & Guérin M (1987). The energetic growth
yields of the yeast Candida parapsilosis. Biology of the Cell, 61: 171-
175.
28. Jarmuszkiewicz W, Milani G, Fortes F, Schreiber AZ, Sluse FE &
Vercesi AE (2000). First evidence and characterization of an uncou-
pling protein in fungi kingdom: CpUCP of Candida parapsilosis.
FEBS Letters, 467: 145-149.
29. Milani G, Schreiber AZ & Vercesi AE (2001). Ca2+ transport into an
intracellular acidic compartment of Candida parapsilosis. FEBS Let-
ters, 500: 80-84.
30. Gornall AG, Bardawill CJ & David MJ (1949). Determination of
serum proteins by means of the biuret reaction. Biological Chemis-
try, 177: 751-757.
31. Fortes F, Castilho RF, Catisti R, Carnieri EGS & Vercesi AE (2001).
Ca2+ induces a cyclosporin A-insensitive permeability transition
pore in isolated potato tuber mitochondria mediated by reactive
oxygen species. Journal of Bioenergetics and Biomembranes, 33:
43-51.
32. Borecký J, Maia IG, Costa ADT, Jeñek P, Chaimovich H, Andrade
PMB, Vercesi AE & Arruda P (2001). Functional reconstitution of
Arabidopsis thaliana plant uncoupling mitocondrial protein
(AtPUMP1) expressed in Escherichia coli. FEBS Letters, 505: 240-
244.
33. ElMoualij B, Duyckaerts C, Lamotte-Brasseur J & Sluse FE (1997).
Phylogenetic classification of the mitochondrial carrier family of
Saccharomyces cerevisiae. Yeast, 13: 573-581.
34. Hourton-Cabassa C, Matos AR, Zachowski A & Moreau F (2004).
The plant uncoupling protein homologues: a new family of energy-
dissipating proteins in plant mitochondria. Plant Physiology and
Biochemistry, 42: 283-290.
35. ðá…ková M & Jeñek P (2002). Reconstitution of novel mitochondrial
uncoupling proteins UCP2 and UCP3. Bioscience Reports, 22: 33-
47.
36. Jeñek P, Engstová H, ða…hová M, Vercesi AE, Costa ADT, Arruda P
& Garlid KD (1998). Fatty acid cycling mechanism and mitochondrial
uncoupling proteins. Biochimica et Biophysica Acta, 365: 319-327.
37. Jabçrek M, VaÍecha M, Gimeno RE, Dembski M, Jeñek P, Zhang M,
Burn P, Tartaglia LA & Garlid KD (1999). Transport function and
regulation of mitochondrial uncoupling proteins 2 and 3. Journal of
Biological Chemistry, 264: 26003-26007.
38. Jeñek P, Costa ADT & Vercesi AE (1996). Evidence for anion-
translocating plant uncoupling mitochondrial protein in potato mito-
chondria. Journal of Biological Chemistry, 261: 32743-32748.
39. Jarmuszkiewicz W, Sluse-Goffart CM, Vercesi AE & Sluse FE (2001).
Alternative oxidase and uncoupling protein: thermogenesis versus
cell energy balance. Bioscience Reports, 21: 213-222.
